首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.
【24h】

Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.

机译:类风湿关节炎:类风湿因子水平与CA-125肿瘤标志物升高之间的相关性。

获取原文
获取原文并翻译 | 示例
       

摘要

Rheumatoid factors (RFs) are autoantibodies directed against the Fc portion of IgG. Tumour markers (eg, CA-125, CA-19-9) are tumour-expressed proteins that are usually measured in the serum by means of ELISA sandwich assays, in which murine monoclonal antibodies are used to capture the circulating antigen under investigation. Given the extensive homology between the Fc regions of murine and human IgG antibodies, it may not be unexpected that anecdotal reports have shown that tumour markers can be falsely increased in the presence of human antimouse antibodies or RPs. We systematically sought to determine whether patients with active RF-positive rheumatoid arthritis (RA) and no evidence of a neoplastic disorder could have "falsely" increased levels of some commonly tested serum tumour markers.
机译:类风湿因子(RF)是针对IgG Fc部分的自身抗体。肿瘤标志物(例如CA-125,CA-19-9)是通常在血清中通过ELISA夹心测定法测量的肿瘤表达蛋白,其中鼠单克隆抗体用于捕获正在研究的循环抗原。鉴于鼠类Fc区和人IgG抗体之间的广泛同源性,轶事报道显示,在存在人类抗小鼠抗体或RP的情况下,肿瘤标志物可能会错误地增加,这并不意外。我们系统地寻求确定患有活动性RF阳性类风湿关节炎(RA)且无肿瘤性疾病证据的患者是否可以“错误地”增加某些通常测试的血清肿瘤标志物的水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号